Table: Hisamitsu -2017/18 group results

Hisamitsu Pharmaceutical Co

10/04/2018 07:00

Apr 10 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2018    Feb 28, 2017   Feb 28, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            147.87          145.93         148.50                 
                 (+1.3 pct)      (-9.8 pct)     (+0.4 pct)               
  Operating         26.35           26.31          24.00                 
                 (+0.2 pct)      (-5.1 pct)     (-8.9 pct)               
  Recurring         28.25           28.18          26.30                 
                 (+0.2 pct)      (+0.6 pct)     (-6.9 pct)               
  Net
  Net               19.12           20.40          19.20                 
                 (-6.3 pct)      (+14.7 pct)    (+0.4 pct)               
  EPS            228.52 yen      241.27 yen     229.49 yen               
  EPS Diluted    228.35 yen      241.15 yen                              
  Ann Div         82.00 yen       81.50 yen      82.50 yen               
  -Q2 Div         41.00 yen       40.50 yen      41.25 yen               
  -Q4 Div         41.00 yen       41.00 yen      41.25 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T